← Leaderboards
Umrao Monani
Columbia University Health Sciences
$8,251,575
Attributed
$8,251,575
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,251,575 · 6
By mechanism
R01$7,114,375 · 3
R56$532,700 · 1
R21$440,000 · 1
R03$164,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Livio Pellizzoni$13,515,447
- George Z Mentis$12,085,277
- Howard J Worman$18,931,900
- Gregg G Gundersen$21,629,601
- Sarah R Tisdale$127,140
Others in their field
Top investigators on “Phenotype”
- David R. Weir · University Of Michigan At Ann Arbor$239,033,262
- David Heimbrook · Leidos Biomedical Research, Inc.$213,586,034
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Richard A Gibbs · Baylor College Of Medicine$184,906,270
- James E. Gern · University Of Wisconsin-Madison$141,704,104
- Garret A Fitzgerald · University Of Pennsylvania$141,348,491
Research focus
PhenotypeDisease PhenotypeMouse ModelReportingGenesSpinal Muscular AtrophyCellsMotor NeuronsProteinsMutationNeuromuscular DiseasesNeuromuscular SystemDefectSmn2 GenePathway InteractionsMolecularNeuron LossSpinalHuman DiseaseLightEffective TherapyMusclePathologyTranslating
Grant awards (23)
Mechanisms and SMN-Independent Therapies for Spinal Muscular Atrophy$435,905
R01 · FY2025 · NS · contact PI
Mechanisms and SMN-Independent Therapies for Spinal Muscular Atrophy$469,809
R01 · FY2024 · NS · contact PI
Mechanisms and SMN-independent therapies for spinal muscular atrophy$484,338
R01 · FY2023 · NS · contact PI
Mechanisms and SMN-independent therapies for spinal muscular atrophy$576,643
R01 · FY2022 · NS · contact PI
Spinal muscular atrophy: Mechanisms & treatment strategies.$396,649
R01 · FY2022 · NS · contact PI
A "humanized" mouse model of Glut1 deficiency syndrome.$164,500
R03 · FY2022 · NS · contact PI
Spinal muscular atrophy: Mechanisms & treatment strategies.$396,648
R01 · FY2021 · NS · contact PI
Spinal muscular atrophy: Mechanisms & treatment strategies.$396,648
R01 · FY2020 · NS · contact PI
Spinal muscular atrophy: Mechanisms and treatment strategies$384,491
R01 · FY2020 · NS · contact PI
Spinal muscular atrophy: Mechanisms & treatment strategies.$460,303
R01 · FY2019 · NS · contact PI
Spinal muscular atrophy: Mechanisms and treatment strategies.$532,700
R56 · FY2018 · NS · contact PI
The Spinal Muscular Atrophy NMJ phenotype: mechanisms and molecular mediators$240,000
R21 · FY2018 · NS · contact PI
The Spinal Muscular Atrophy NMJ phenotype: mechanisms and molecular mediators$200,000
R21 · FY2017 · NS · contact PI
Novel genetic determinants of the neuromuscular SMA phenotype$350,000
R01 · FY2016 · NS · contact PI
Novel genetic determinants of the neuromuscular SMA phenotype$350,000
R01 · FY2015 · NS · contact PI
Novel genetic determinants of the neuromuscular SMA phenotype$346,501
R01 · FY2014 · NS · contact PI
Novel genetic determinants of the neuromuscular SMA phenotype$337,750
R01 · FY2013 · NS · contact PI
Novel genetic determinants of the neuromuscular SMA phenotype$350,000
R01 · FY2012 · NS · contact PI
The contributing effects of muscle, nerve and the NMJ to SMA pathology$337,298
R01 · FY2011 · NS · contact PI
The contributing effects of muscle, nerve and the NMJ to SMA pathology$340,972
R01 · FY2010 · NS · contact PI
The contributing effects of muscle, nerve and the NMJ to SMA pathology$344,642
R01 · FY2009 · NS · contact PI
The contributing effects of muscle, nerve and the NMJ to SMA pathology$24,260
R01 · FY2009 · NS · contact PI
The contributing effects of muscle, nerve and the NMJ to SMA pathology$331,518
R01 · FY2008 · NS · contact PI